Prisinformation från TradingView

Bolagspresentation:

Nyhetsflöde Consti

Related articles:
4/18/2024 7:30:28 AM - Consti: Slower start to the year expected - Evli - Consti reports its Q1/24 results on 25th of April. We expect continued sales decline during the seasonally slow Q1 as a result of the strong comparison period Q1/23 and lower order intake during H2/23.
2/5/2024 6:31:33 AM - Consti: Market presents some challenges - Evli - Consti’s Q4 figures missed our estimates mainly due to lower volumes than expected. The company expects EBIT of EUR 9-12m for 2024, the range is rather conservative in our view and reflects the low visibility to market development.
2/2/2024 8:24:39 AM - Consti: Weaker finish to the year than expected - Evli - Consti's net sales in Q4 amounted to EUR 86.1m, below our estimates (Evli est. EUR 96.1m.), with decline of 7.7% y/y. EBIT amounted to EUR 3.9m, also weaker than our estimates (Evli est. EUR 4.8m).
1/26/2024 9:07:46 AM - Consti: Closing out another solid year - Evli - Consti reports its Q4 figures on 2nd of February. We expect a solid finish to the year despite continued salary inflation as we expect slight net sales growth for the quarter.
10/31/2023 6:42:48 AM - Consti: Solid performance continues - Evli - Consti’s steady development continued with slightly higher than expected growth during the Q3. With the gain from the sale of relining business, the company is pushing the higher limit of the current guidance.
10/27/2023 11:44:00 AM - Consti: Strong performance - Evli - Consti's net sales in Q3 amounted to EUR 89.9m above our estimates (Evli est. EUR 81.5m.), with growth of 13.8% y/y. EBIT amounted to EUR 4.8m, clearly above our estimates (Evli est. EUR 3.4m) driven partly by the sale of the company’s relining business.
10/19/2023 5:15:12 AM - Consti: Valuation doesn’t set the bar high - Evli - Consti reports its Q3 results on 27th of October. We expect continued good execution supported by the strong backlog. We continue to keep an eye on order intake and the future outlook as the renovation market sentiment shows signs of weakness.
9/25/2023 6:51:19 AM - Tebede gör förvärv i Finland (uppdatering) - (Spac-beskrivning av Tebede bortplockad)
9/25/2023 6:07:12 AM - Tebede gör förvärv i Finland - Spac-bolaget Tebede har via dotterbolaget Spolargruppen Sverige ingått avtal om förvärv av tillgångarna i reliningverksamheten Consti Sukitus i Finland. Det framgår av ett pressmeddelande.
7/21/2023 1:10:57 PM - Consti: Smooth sailing - Evli - Consti’s Q2 report provided no real surprises, and the figures were largely in line with our estimates. Our focus for Q2 was on the company’s order intake which came in strong at EUR 106.5m in Q2 (Q2/22: EUR 98.7m). We see continued steady development going forward backed by the healthy backlog.
7/21/2023 6:49:17 AM - Consti: Steady development, strong orders - Evli - Consti's net sales in Q2 amounted to EUR 75.7m, roughly in line with our and consensus estimates (EUR 79.8m/77.7m Evli/cons.), with growth of 3.6% y/y. EBIT amounted to EUR 3.0m, also in line with our and consensus estimates (EUR 3.1m/3.1m Evli/cons.). Guidance for FY 2023 (unchanged): operating result for 2023 will be in the range of EUR 9.5–13.5 million
4/28/2023 8:51:05 AM - Consti: Delivering as expected, plus some more - Evli - Consti reported Q1 figures that were above our estimates. We continue to see the valuation undemanding as the company keeps delivering strong figures. After only slight adjustments to our estimates, we retain our BUY-rating with TP of EUR 14.0 (14.0)
4/27/2023 8:35:47 AM - Consti: Another strong quarter - Evli - Consti's net sales in Q1 amounted to EUR 68.9m, above our and consensus estimates (EUR 62.5m/62.3m Evli/cons.), with impressive growth of 15.2% y/y. EBIT amounted to EUR 0.7m, also above our and consensus estimates (EUR 0.5m/0.5m Evli/cons.). Guidance for FY 2023 remains unchanged.
4/20/2023 6:25:09 AM - Consti: Expecting a solid yet seasonally slow Q1 - Evli - Consti reports its Q1 2023 earnings on 27th of April. We expect the positive development seen during 2022 to continue driven by the company’s healthy backlog, higher volumes and slower construction cost inflation. With estimates intact, we retain our BUY rating and TP of EUR 14.0.
2/6/2023 8:24:28 AM - Consti: Strong finish to the year - Evli - Consti’s Q4 results were strong as both revenue and profitability figures exceeded our estimates. The valuation is still rather undemanding despite the recent share price strength, we also see the dividend yield attractive. We retain our BUY-rating and adjust our target price to EUR 14.0 (13.0).
2/3/2023 8:48:21 AM - Consti: Even stronger than expected - Evli - Consti's net sales in Q4 amounted to EUR 93.3m, above our and consensus estimates (EUR 85.1m/86.0m Evli/cons.), with growth of 12.9% y/y. EBIT amounted to EUR 4.8m, also above our and consensus estimates (EUR 3.7m/3.4m Evli/cons.). Guidance for FY 2023: operating result for 2023 will be in the range of EUR 9.5–13.5 million.
1/30/2023 8:17:37 AM - Consti: Positive development expected - Evli - Consti reports its Q4 2022 results on February 3rd. We expect that the steady performance continues, and operative profitability improves year-on-year. We retain our BUY-rating and adjust our target price to EUR 13.0 (12.0).
12/29/2022 7:33:21 AM - Consti: Steady progress, favourable valuation - Evli - Consti is the leading renovation construction company in Finland. Despite facing an uncertain market with rising building costs, the company has been able to successfully turnaround and maintain its profitability. We continue to see the valuation rather undemanding and the discount to its main peers unjustified. We retain our BUY-rating and adjust our target price to EUR 12.0 (11.0).
10/28/2022 8:03:10 AM - Consti: Steady development in a difficult market - Evli - Consti reported Q3 figures that were in line with our estimates. The company was able to defend its margins in a difficult market environment. Consti’s order backlog decreased slightly but remains at healthy levels, which supports the company’s near-term development. Although the construction market outlook is quite grim, the near-term growth outlook for renovation construction remains decent. We retain our BUY-rating and TP of EUR 11.0.
10/27/2022 8:21:53 AM - Consti: In line with our estimates - Evli - Consti's net sales in Q3 amounted to EUR 79.0m, in line with our and consensus estimates (EUR 79.8m/79.6m Evli/cons.), with growth of 4.0% y/y. EBIT amounted to EUR 3.3m, in line with our and consensus estimates (EUR 3.2m/3.3m Evli/cons.). Guidance reiterated: operating result in 2022 is expected to be EUR 9-13m.
10/24/2022 8:40:29 AM - Consti: Market outlook of key interest - Evli - Consti reports Q3 results on October 27th. Financials are of lesser interest, with some cost impact likely, while the currently mixed market outlook is of key interest.
7/25/2022 7:14:01 AM - Consti: On track towards y/y improvement - Evli - Consti reported Q2 results that corresponded quite well with expectations. Prevailing market conditions still create some uncertainties for the end of the year but overall, the outlook is still quite positive. We retain our target price of EUR 12.0 per share and BUY-rating.
7/22/2022 7:36:03 AM - Consti: Well in line with expectations - Evli - Consti's net sales in Q2 amounted to EUR 73.1m, in line with our and consensus estimates (EUR 74.6m/74.7m Evli/cons.), with growth of 3.1% y/y. EBIT amounted to EUR 2.9m, in line with our and consensus estimates (EUR 3.0m/2.9m Evli/cons.). Guidance reiterated: operating result in 2022 is expected to be EUR 9-13m.
5/2/2022 7:03:17 AM - Consti: Some headwind seen - Evli - Consti saw some seasonal softness in growth in Q1. Demand and construction material uncertainty continues to have an impact, but we still see the renovation market being fairly well positioned.
4/29/2022 8:53:47 AM - Consti: Some softness in growth - Evli - Consti's net sales in Q1 amounted to EUR 59.8m, slightly below our and consensus estimates (EUR 63.3m/64.4m Evli/cons.), with growth of 0.9% y/y. EBIT amounted to EUR 0.4m, slightly above our estimates and in line with consensus (EUR 0.0m/0.4m Evli/cons.). Guidance reiterated: operating result in 2022 is expected to be EUR 9-13m.
4/27/2022 7:25:19 AM - Consti: Elevated material uncertainty - Evli - Consti reports its Q1 results on April 29th. Concerns relating to material pricing and availability have increased due to Ukraine crisis, although Consti through its renovation focus should be less affected than constructors. We retain our BUY-rating with a TP of EUR 13.0 (14.0).
2/7/2022 8:40:44 AM - Consti: Steadily moving forward - Evli - Consti’s Q4 results were on the softer side, with some performance challenges in two regional business units. The guidance implies rather healthy margins in 2022. We retain our BUY-rating with a TP of EUR 14.0 (14.5).
2/4/2022 7:13:17 AM - Consti: Guidance in line with expectations - Evli - Consti's net sales in Q4 amounted to EUR 82.6m, below our and consensus estimates (EUR 86.9m/86.4m Evli/cons.), with growth of 5.8% y/y. EBIT amounted to EUR 3.0m, below our and consensus estimates (EUR 3.7m/3.4m Evli/cons.). The BoD proposes a dividend of EUR 0.45 per share (EUR 0.35/0.41 Evli/cons.). Operating result in 2022 is expected to be EUR 9-13m.
2/2/2022 8:03:02 AM - Consti: Profitable growth track in place - Evli - Consti reports its Q4 results on February 4th. We expect double-digit growth, with some margin uncertainty due to the situation with construction materials. Growth is set to continue in 2022 supported by the order backlog and previous acquisition, with some potential for margin improvement depending on the market situation.
10/28/2021 8:20:06 AM - Consti: Good growth, minor margin concerns - Evli - Consti reported good Q3 results, with growth picking up better than anticipated and profitability improving y/y. Construction material costs and availability cause some concern for margins in coming quarters but overall, the outlook still remains favourable. We retain our target price of EUR 14.5 and BUY-rating.
10/27/2021 7:17:12 AM - Consti: Growth picking up nicely - Evli - Consti's net sales in Q3 amounted to EUR 76.0m, slightly above our and consensus estimates (EUR 73.3m/73.0m Evli/cons.), with growth picking up clearly to 11.4% y/y. EBIT amounted to EUR 3.1m, above our and consensus estimates (EUR 2.7m Evli/cons.). The order backlog continued to grow well, up 15.0% to EUR 217.9m.
10/25/2021 7:37:03 AM - Consti: Eyeing pick-up in growth - ABG - Consti will report its Q3 results on October 27th. We expect to see growth to start picking up supported by the good order intake during H1 and for profitability to remain at healthy levels. We retain our BUY-rating and TP of EUR 14.5.
7/26/2021 7:46:25 AM - Consti: Good progress but margin pressure ahead - Danske Bank - We were impressed by Consti’s solid operative progress ahead of a more challenging<br>H2. In the bigger picture, we believe the final decision in the long-standing dispute is a<br>big step forward as it derisks the company. We see the current valuation as fair for<br>Consti, as it trades at 12.6x and 9.8x on on adjusted EBIT 2021E and 2022E, which is 12-<br>16% below Nordic constructor peers. We keep our fair valuation range at EUR12-14.
7/26/2021 6:06:42 AM - Consti: Upgrade to buy - Evli Research - Q2 better than expected on adj. basis
7/23/2021 6:07:58 AM - Consti: Rather upbeat report - Evli Research - Consti's net sales in Q2 amounted to EUR 70.9m, in line with our and consensus estimates (EUR 68.5m/69.2m Evli/cons.). EBIT amounted to EUR -0.5m, in line with our and consensus estimates (EUR -0.4m/-0.7m Evli/cons.). The order backlog was up 11.5% to EUR 236.5m. Excluding one-offs the report was in our view rather upbeat, in particular on order intake.
7/21/2021 5:38:18 AM - Consti: One-off to burden Q2 results - Evli Research - Arbitration proceedings outcome to burden Q2 results
6/15/2021 6:59:04 AM - Consti: Unfortunate one-off earnings hit - Evli Research - The arbitration proceedings relating to the Hotel St. George project unfortunately came to a for Consti unfavourable conclusion. As a result, Consti lowered its 2021 operating result estimate to EUR 4-8m (EUR 7-11m). Our 2021 estimate is now EUR 5.7m (EUR 8.7m), TP of EUR 13.0 and HOLD-rating intact.
5/3/2021 11:40:46 AM - Consti: Soft result, solid orders - Danske Bank - We do not see much drama in the soft Q1 results as order intake keeps improving. The next trigger is the big decision from the arbitration proceedings, which is expected before 11 June. We keep our fair valuation range to EUR12-14.
4/30/2021 5:56:44 AM - Consti: Slightly softer than expected start - Evli - Consti's net sales in Q1 amounted to EUR 59.3m, in line with our and consensus estimates (EUR 60.2m/60.2m Evli/cons.). EBIT amounted to EUR 0.1m, below our and consensus estimates (EUR 0.5m/0.6m Evli/cons.). 2021 operating profit guidance of EUR 7-11m intact.
4/28/2021 5:55:24 AM - Consti: Eyes on demand development - Evli Research - Looking for signs of growth
2/8/2021 9:16:51 AM - Consti: Derisked ahead of important decision - Danske Bank - Consti delivered a strong ending to 2020, with resilient revenue and order intake. Margin<br>delivery was again precise. With the help of strong cash flow, we believe Consti has<br>derisked already ahead of the arbitration decision, as net debt to EBITDA has declined<br>to 0.6x. We raise our fair valuation range to EUR12-14.
2/8/2021 9:15:36 AM - Consti: Good and steady performance - Evli Research - Q4 slightly above expectations
2/5/2021 8:11:06 AM - Consti: Good finish to the year - Evli Research - Consti's net sales in Q4 amounted to EUR 78.1m, above our estimates and consensus estimates (EUR 71.6m/71.1m Evli/cons.). EBIT amounted to EUR 3.0m, slightly above our and consensus estimates (EUR 2.7m/2.7m Evli/cons.). Dividend proposal EUR 0.40 per share (0.35 Evli/cons.). 2021 EBIT guidance EUR 7-11m.
2/3/2021 9:48:36 AM - Consti: Steady finish to year expected - Evli Research - Expect a good finish to a year of improvement
10/30/2020 10:02:46 AM - Aktiespararen ger köpråd för Skanska, Consti, Haldex, Climeon och Drillcon - Aktiespararen rekommenderar köp av Skanska, finska Consti, Haldex, Climeon och Drillcon i den senaste utgåvan. Tidningen ger rådet avvakta för Biogaia.